Literature DB >> 1672770

Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome.

E DeFreitas1, B Hilliard, P R Cheney, D S Bell, E Kiggundu, D Sankey, Z Wroblewska, M Palladino, J P Woodward, H Koprowski.   

Abstract

Chronic fatigue immune dysfunction syndrome (CFIDS) is a recently recognized illness characterized by debilitating fatigue as well as immunological and neurological abnormalities [Straus, S.E. (1988) J. Inf. Dis. 157, 405-412]. Once thought to be caused by Epstein-Barr virus, it is now thought to have a different but unknown etiology. We evaluated 30 adult and pediatric CFIDS patients from six eastern states for the presence of human T-lymphotropic virus (HTLV) types I and II by Western immunoblotting, polymearse chain reaction, and in situ hybridization of blood samples. The majority of patients were positive for HTLV antibodies by Western blotting and for HTLV-II gag sequences by polymerase chain reaction and in situ hybridization. Twenty nonexposure healthy controls were negative in all assays. These data support an association between an HTLV-II-like virus and CFIDS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672770      PMCID: PMC51352          DOI: 10.1073/pnas.88.7.2922

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease and epidemic neuromyasthenia.

Authors:  E D ACHESON
Journal:  Am J Med       Date:  1959-04       Impact factor: 4.965

2.  Chronic fatigue syndrome: a working case definition.

Authors:  G P Holmes; J E Kaplan; N M Gantz; A L Komaroff; L B Schonberger; S E Straus; J F Jones; R E Dubois; C Cunningham-Rundles; S Pahwa
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

3.  The chronic fatigue syndrome--one entity or many?

Authors:  M N Swartz
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

4.  Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.

Authors:  M Caligiuri; C Murray; D Buchwald; H Levine; P Cheney; D Peterson; A L Komaroff; J Ritz
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

5.  What is myalgic encephalomyelitis?

Authors:  A R Lloyd; D Wakefield; C Boughton; J Dwyer
Journal:  Lancet       Date:  1988-06-04       Impact factor: 79.321

6.  A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause?

Authors:  G P Holmes; J E Kaplan; J A Stewart; B Hunt; P F Pinsky; L B Schonberger
Journal:  JAMA       Date:  1987-05-01       Impact factor: 56.272

7.  Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial.

Authors:  S E Straus; J K Dale; M Tobi; T Lawley; O Preble; R M Blaese; C Hallahan; W Henle
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

Review 8.  Human B-lymphotropic virus (human herpesvirus-6).

Authors:  D V Ablashi; S F Josephs; A Buchbinder; K Hellman; S Nakamura; T Llana; P Lusso; M Kaplan; J Dahlberg; S Memon
Journal:  J Virol Methods       Date:  1988-09       Impact factor: 2.014

9.  A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia.

Authors:  V S Kalyanaraman; M G Sarngadharan; M Robert-Guroff; I Miyoshi; D Golde; R C Gallo
Journal:  Science       Date:  1982-11-05       Impact factor: 47.728

10.  Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors.

Authors:  A E Williams; C T Fang; D J Slamon; B J Poiesz; S G Sandler; W F Darr; G Shulman; E I McGowan; D K Douglas; R J Bowman
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

View more
  23 in total

Review 1.  Toward a model of social course in chronic illness: the example of chronic fatigue syndrome.

Authors:  N C Ware
Journal:  Cult Med Psychiatry       Date:  1999-09

2.  Multiplex detection of four pathogenic retroviruses using molecular beacons.

Authors:  J A Vet; A R Majithia; S A Marras; S Tyagi; S Dube; B J Poiesz; F R Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

3.  A cautionary tale of virus and disease.

Authors:  Robin A Weiss
Journal:  BMC Biol       Date:  2010-09-27       Impact factor: 7.431

Review 4.  The chronic fatigue syndrome.

Authors:  D G James; M G Brook; B A Bannister
Journal:  Postgrad Med J       Date:  1992-08       Impact factor: 2.401

5.  Antibody to human endogenous retrovirus peptide in urine of human immunodeficiency virus type 1-positive patients.

Authors:  R W Stevens; A L Baltch; R P Smith; B J McCreedy; P B Michelsen; L H Bopp; H B Urnovitz
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

6.  Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

Authors:  Mary A Fletcher; Xiao R Zeng; Kevin Maher; Silvina Levis; Barry Hurwitz; Michael Antoni; Gordon Broderick; Nancy G Klimas
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

7.  Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States.

Authors:  William M Switzer; Hongwei Jia; Oliver Hohn; HaoQiang Zheng; Shaohua Tang; Anupama Shankar; Norbert Bannert; Graham Simmons; R Michael Hendry; Virginia R Falkenberg; William C Reeves; Walid Heneine
Journal:  Retrovirology       Date:  2010-07-01       Impact factor: 4.602

Review 8.  Treatment of the chronic fatigue syndrome. A review and practical guide.

Authors:  E Blondel-Hill; S D Shafran
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

9.  Plasma cytokines in women with chronic fatigue syndrome.

Authors:  Mary Ann Fletcher; Xiao Rong Zeng; Zachary Barnes; Silvina Levis; Nancy G Klimas
Journal:  J Transl Med       Date:  2009-11-12       Impact factor: 5.531

10.  Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome.

Authors:  Otto Erlwein; Steve Kaye; Myra O McClure; Jonathan Weber; Gillian Wills; David Collier; Simon Wessely; Anthony Cleare
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.